Cost-effectiveness of apixaban versus other oral anticoagulants and aspirin for stroke prevention in atrial fibrillation in indian subcontinent

被引：1
|
作者：
Kulkarni, N. [1 ]
Taur, S. [1 ]
Tichy, E. [2 ]
Kongnakorn, T. [3 ]
Sharma, R. [4 ]
机构：
[1] Pfizer India, Med Affairs, Mumbai, Maharashtra, India
[2] Evidera, Budapest, Hungary
[3] Evidera, London, England
[4] Fortis Hosp, Mohali, India
来源：
EUROPEAN HEART JOURNAL | 2022年 / 43卷
关键词：
D O I：
10.1093/eurheartj/ehab849.022
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the Novel Oral Anticoagulants
    Kasmeridis, Charalampos
    Apostolakis, Stavros
    Ehlers, Lars
    Rasmussen, Lars H.
    Boriani, Giuseppe
    Lip, Gregory Y. H.
    PHARMACOECONOMICS, 2013, 31 (11) : 971 - 980
  • [42] Comparative cost-effectiveness of oral anticoagulants for stroke prevention in non-valvular atrial fibrillation patients in the UK
    Lip, G. Y. H.
    Lanitis, T.
    Kongnakorn, T.
    Phatak, H.
    Liu, L.
    Lawrence, J.
    Dorian, P.
    EUROPEAN HEART JOURNAL, 2015, 36 : 864 - 864
  • [43] Cost-effectiveness of warfarin care bundles and novel oral anticoagulants for stroke prevention in patients with atrial fibrillation in Thailand
    Ng, Siok Shen
    Nathisuwan, Surakit
    Phrommintikul, Arintaya
    Chaiyakunapruk, Nathorn
    THROMBOSIS RESEARCH, 2020, 185 : 63 - 71
  • [44] COST-EFFECTIVENESS OF NEWER ANTICOAGULANTS FOR STROKE PREVENTION IN ATRIAL FIBRILLATION: A SYSTEMATIC LITERATURE REVIEW
    Coleman, C., I
    Baker, W. L.
    Limone, B. L.
    VALUE IN HEALTH, 2013, 16 (03) : A287 - A287
  • [45] Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Review of Cost-Effectiveness Models
    Limone, Brendan L.
    Baker, William L.
    Kluger, Jeffrey
    Coleman, Craig I.
    PLOS ONE, 2013, 8 (04):
  • [46] COST-EFFECTIVENESS OF WARFARIN CARE BUNDLES AND NOVEL ORAL ANTICOAGULANTS FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION IN THAILAND
    Ng, S. S.
    Nathisuwan, S.
    Phrommintikul, A.
    Chaiyakunapruk, N.
    VALUE IN HEALTH, 2019, 22 : S551 - S551
  • [47] Comparison of the Cost-effectiveness of New Oral Anticoagulants for the Prevention of Stroke and Systemic Embolism in Atrial Fibrillation in a UK Setting
    Zheng, Ying
    Sorensen, Sonja V.
    Gonschior, Ann-Katrin
    Noack, Herbert
    Heinrich-Nols, Jutta
    Sunderland, Tom
    Kansal, Anuraag R.
    CLINICAL THERAPEUTICS, 2014, 36 (12) : 2015 - +
  • [48] COST-EFFECTIVENESS OF NOVEL ORAL ANTICOAGULANTS FOR STROKE PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN CHINA
    Guo, W.
    Tian, X.
    Li, W.
    Han, S.
    VALUE IN HEALTH, 2018, 21 : S30 - S30
  • [49] Pharmacogenetic-guided selection of warfarin versus novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: a cost-effectiveness analysis
    You, Joyce H. S.
    PHARMACOGENETICS AND GENOMICS, 2014, 24 (01): : 6 - 14
  • [50] Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia
    Hersi, Ahmad S.
    Osenenko, Katherine M.
    Kherraf, Sid Ahmed
    Aziz, Ayman Abdel
    Sambrook, Robert Joseph
    ANNALS OF SAUDI MEDICINE, 2019, 39 (04) : 265 - 278
12345